ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,180 | -53.3% | 60,120 | -50.5% | 0.02% | -56.2% |
| Q2 2023 | $193,015 | +121.6% | 121,393 | 0.0% | 0.05% | +108.7% |
| Q1 2023 | $87,088 | +23.8% | 121,393 | 0.0% | 0.02% | +9.5% |
| Q4 2022 | $70,347 | -23.5% | 121,393 | +25.3% | 0.02% | -27.6% |
| Q3 2022 | $92,000 | -42.1% | 96,910 | -27.0% | 0.03% | -35.6% |
| Q2 2022 | $159,000 | +84.9% | 132,769 | +101.9% | 0.04% | +125.0% |
| Q1 2022 | $86,000 | -9.5% | 65,754 | +21.8% | 0.02% | 0.0% |
| Q4 2021 | $95,000 | -4.0% | 54,000 | +18.4% | 0.02% | -9.1% |
| Q3 2021 | $99,000 | +4.2% | 45,603 | +75.4% | 0.02% | -38.9% |
| Q3 2017 | $95,000 | +46.2% | 25,998 | 0.0% | 0.04% | +33.3% |
| Q2 2017 | $65,000 | +1.6% | 25,998 | +9.5% | 0.03% | +3.8% |
| Q1 2017 | $64,000 | – | 23,746 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |